Private Placement

Nepra Foods Inc. announced a non-brokered private placement to raise up to $500,000. The offering involves issuing units at $0.06 each, comprising a common share and a warrant. Funds will be used for working capital. Closing is subject to regulatory approvals. Nepra Foods, a specialist in allergen- and gluten-free food ingredients, aims to strengthen its position in the healthy food market through this financing.

Quince Therapeutics announced a securities purchase agreement to raise approximately $11.5 million upfront, with the potential for an additional $10.4 million if warrants are exercised. The financing, priced at a premium, will fund working capital, R&D, and general corporate purposes, extending its operational runway into Q2 2026 (or potentially H2 2026). The placement is led by Nantahala Capital and is set to close in June 2025.

CyberArk is issuing $1.1 billion in 0.00% convertible senior notes due 2030, upsized from $750 million. The notes are exchangeable for CyberArk shares at an initial conversion price of roughly $509.84, a 30% premium. The company has also entered into capped call transactions to mitigate dilution. Proceeds will fund corporate purposes, potentially including acquisitions.

VivoPower International PLC (VVPR) corrected its May 28, 2025 press release regarding its XRP digital asset strategy and a $121 million private placement. The company is shifting towards the XRP space, acquiring and managing XRP as part of a diversified digital treasury to support the XRP Ledger and DeFi infrastructure. This strategic pivot reflects a commitment to digital assets, with forward-looking statements subject to risks and uncertainties.

IMPACT Silver (TSXV: IPT) raised C$3.93 million via a dual-tranche private placement, combining C$1.66 million from a LIFE offering (C$0.20/unit) and C$2.27 million from standard units (C$0.18/unit), with tiered warrants exercisable at C$0.24–0.26. Proceeds will accelerate exploration at Mexico’s Plomosas zinc-lead-silver project and revive the Zacualpan silver district, alongside operational upgrades. The financing introduces 15% dilution (20.9M shares), potentially reaching 31.7% if warrants fully convert. While immediate liquidity from LIFE shares benefits investors, challenges include declining Zacualpan silver grades and discontinuous mineralization at Plomosas requiring new discoveries to offset risks.

Southern Company priced $1.45 billion in 3.25% Convertible Senior Notes due 2028, a $200 million increase from its initial target. The notes, convertible at $113.54/share (25% premium over May 20 closing price), were issued privately under SEC Rule 144A. Proceeds (~$1.44 billion, rising to $1.63 billion if options are exercised) will refinance existing debt, cover commercial paper, and support corporate activities, including potential subsidiary investments. Southern noted potential stock volatility due to investor hedging adjustments. The offering, set to close by May 23, 2025, excludes public registration, restricting resale under U.S. securities laws.